(MedPage Today) — The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults, Johnson & Johnson announced.
Lumateperone was previously approved as an adjunctive…
Source link : https://www.medpagetoday.com/psychiatry/depression/118356
Author :
Publish date : 2025-11-06 21:18:00
Copyright for syndicated content belongs to the linked Source.
